Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia
about
How we diagnose neutropenia in the adult and elderly patientThe relationship between idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and autoimmunity.Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion.Abnormal telomere shortening of peripheral blood mononuclear cells and granulocytes in patients with chronic idiopathic neutropenia.Genetic associations in acquired immune-mediated bone marrow failure syndromes: insights in aplastic anemia and chronic idiopathic neutropenia.Clonal predominance of CD8(+) T cells in patients with unexplained neutropeniaPathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia.Pathophysiologic mechanisms and management of neutropenia associated with large granular lymphocytic leukemia.How we diagnose and treat neutropenia in adults.Minor populations of paroxysmal nocturnal hemoglobinuria-type cells in patients with chronic idiopathic neutropenia.Increased expression of chemokine receptor CCR3 and its ligands in ulcerative colitis: the role of colonic epithelial cells in in vitro studies.CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid.Cytotoxic T cells in chronic idiopathic neutropenia express restricted antigen receptors.Lymphopenia in patients with chronic idiopathic neutropenia is associated with decreased number of T-lymphocytes containing T-cell receptor excision circles.The role of CD40/CD40 ligand interactions in bone marrow granulopoiesis.The -509C/T polymorphism of transforming growth factor-beta1 is associated with increased risk for development of chronic idiopathic neutropenia.
P2860
Q26996404-1525EC59-7C1D-44C5-A34D-6EBD4DC0D21CQ33442467-54793FA0-C49F-445F-858D-FB2F72402BAAQ33707411-E466A5C0-5F95-456C-9497-8CDF773E6C7AQ35930629-887DBF23-0A1F-4DBA-BC20-B21BDB82BA42Q36204561-C82F390C-24DB-4847-AA48-86B46EAB3755Q37098105-A0154064-5F44-4E49-A523-76DF5779E790Q37810067-8C8571B1-54B1-4E76-A1F9-9551310B55CFQ37888717-199DF83C-5F4B-4BC8-BF94-C8B32B384974Q38700289-95CD5C31-6989-4AEE-9ED9-48607200C684Q40777761-2B6EA783-A6D6-4AB6-A8EB-44471BC4D566Q44659810-EBA37461-C2C6-430C-B570-50354B904948Q44906072-A9CA2122-A61A-4FA5-B2B1-9E1BE8B77919Q47755707-42DC24E0-7B0C-46C8-8223-2DFC630D2D4DQ50982627-F264E7A1-C03F-4C2C-8490-A644A7E39BAFQ52618879-69D901EE-5682-4837-8F72-4A86391F00A1Q54472982-5C366B2F-7F56-46C6-903C-83BA1E2D6792
P2860
Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia
description
im März 2005 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2005
@uk
name
Activated T-lymphocytes with m ...... chronic idiopathic neutropenia
@en
Activated T-lymphocytes with m ...... chronic idiopathic neutropenia
@nl
type
label
Activated T-lymphocytes with m ...... chronic idiopathic neutropenia
@en
Activated T-lymphocytes with m ...... chronic idiopathic neutropenia
@nl
prefLabel
Activated T-lymphocytes with m ...... chronic idiopathic neutropenia
@en
Activated T-lymphocytes with m ...... chronic idiopathic neutropenia
@nl
P2093
P2860
P1476
Activated T-lymphocytes with m ...... chronic idiopathic neutropenia
@en
P2093
A. Damianaki
A. G. Eliopoulos
C. Gemetzi
G. D. Eliopoulos
H. A. Papadaki
K. Stamatopoulos
T. Papadaki
P2860
P304
P356
10.1111/J.1365-2141.2005.05380.X
P407
P577
2005-03-01T00:00:00Z